Photo from Rodrigo Sánchez-Bayona/X
Jul 1, 2024, 13:29
Rodrigo Sánchez-Bayona: RWE study of ovarian cancer patients treated with PARP inhibitors at ESMO Gynaecological Cancers Congress 2024
Rodrigo Sánchez-Bayona, Medical Oncologist specialising in breast and gynecological cancers at 12 de Octubre University Hospital, posted on X:
“Thanks to The European Society for Medical Oncology for the Merit Travel Grant to present our RWE study of ovarian cancer patients treated with PARP inhibitors in Spain, a young oncologist collaborative research, in ESMO Gynaecological Cancers Congress 2024.”
Source: Rodrigo Sánchez-Bayona/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 24, 2024, 18:19
Dec 24, 2024, 18:16
Dec 24, 2024, 18:11
Dec 24, 2024, 18:09
Dec 24, 2024, 18:06
Dec 24, 2024, 17:39